Insmed announces pricing of $650 million public offering of common stock

Bridgewater, n.j. , may 30, 2024 /prnewswire/ -- insmed incorporated (nasdaq: insm), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that it priced an underwritten public offering of 12,621,359 shares of its common stock at a price to the public of $51.50 per share.
INSM Ratings Summary
INSM Quant Ranking